ngspro | 1032
NGS Prostate cancer
Keywords
AR, ATM, BARD1, BRAF, BRCA1, BRCA2, BRIP1, CDK12, CHEK1, CHEK2, ERG, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FOXA1, GIS, HOXB13, HRD, IDH1, MLH1, MRE11, MSH2, MSH3, MSH6, MSI, NBN, Next Generation Sequencing, PALB2, PARP1, PIK3CA, PIK3CB, PIK3R1, PMS2, POLD1, POLE, PPP2R2A, PTEN, PTPRT, RAD50, RAD51, RAD51B, RAD51C, RAD51D, RAD52, RAD54L, RET, SPOP, TMB, TP53, TR
| Material |
|
|
| Note |
Full sequencing of genes at the DNA level: AR, ATM, TR, BARD1, BRAF, BRCA1, BRCA2, BRIP1, CDK12, CHEK1, CHEK2, ERG, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FOXA1, HOXB13, IDH1, MLH1, MRE11, MSH2, MSH3, MSH6, NBN, PALB2, PARP1, PIK3CA, PIK3CB, PIK3R1, PMS2, POLD1, POLE, PPP2R2A, PTEN, PTPRT, RAD50, RAD51, RAD51B, RAD51C, RAD51D, RAD52, RAD54L, RET, SPOP, TP53, including tumor mutational burden, genomic instability scores (GIS), and microsatellite instability analysis. To order this analysis, please contact us via contact@viollier.ch or 0848 121 121. This analysis may result in excess information. This will be communicated, unless it is noted otherwise when placing the order. As there may also be indications of hereditary changes, the HGTA (Federal Act on Human Genetic Testing) shall ensure the patient is informed accordingly (see www.viollier.ch/en/SGMG_consent). Tarification: according to Tardoc. |
|
| Duration | 10 days | |
| Frequency | 1 x per week | |
| Method | Next Generation Sequencing | |
| Price | CHF 0.00 | |
| Tariff | 0.00 TP |
Team of consultants
|
MD
Katharina Marston
FMH Pathology, molecular pathology
|
FMH Pathology, molecular pathology | T |
|
|
DSc
Henriette Kurth
FAMH Specialist in laboratory medicine, medical genetics
|
FAMH Specialist in laboratory medicine, medical genetics | T |
|
|
MD
Jean-François Egger
FMH pathology
|
FMH pathology | T |
|
|
PhD
Christoph Noppen
FAMH Specialist in laboratory medicine, medical genetics
|
FAMH Specialist in laboratory medicine, medical genetics | T |
|
|
MD
Santiago Giménez de Mestral
FMH pathology, cytopathology
|
FMH pathology, cytopathology | T |
|